Amylin Pharmaceuticals, Inc. (NASDAQ:AMLN)

Headlines for Amylin Pharmaceuticals, Inc.

Asterand Announces Agreement to Acquire BioSeek
istockAnalyst.com - Nov 18, 2009
(Source: Business Wire) Asterand plc (LSE: ATD), a leading provider of human tissue and human tissue-based services to pharmaceutical and biotechnology companies engaged in drug discovery research ...
Amylin Obesity Drug Grabbing the Attention of Analysts, Investors
San Diego Business Journal - Nov 9, 2009
By HEATHER CHAMBERS In recent months, much of the attention on Amylin Pharmaceuticals Inc. has been focused on its highly publicized proxy fight and the push to get its once-weekly diabetes drug ...
New Report Just Published Amylin Pharmaceuticals Inc - Detailed Product Pipeline
Live-PR.com - Nov 9, 2009
(live-PR.com) - Reportlinker.com announces that a new market research report related to the Pharmaceutical industry is available in its catalogue. contain detailed information on pipelines by ...
Amylin Pharmaceuticals Inc. Reports Operating Results (10-Q)
GuruFocus.com - Nov 5, 2009
Amylin Pharmaceuticals is a biopharmaceutical company committed to improving lives through the discovery development and commercialization of innovative medicines. Amylin has developed and gained ...
Amylin Pharmaceuticals to Present at the 18th Annual Credit Suisse Healthcare Conference
CNNMoney.com - Nov 5, 2009
SAN DIEGO, Nov. 5, 2009 /PRNewswire-FirstCall/ -- Amylin Pharmaceuticals, Inc. (Nasdaq: AMLN) will be presenting at the 18th Annual Credit Suisse Healthcare Conference in Phoenix, Arizona on ...